Some gene therapies can provide long-lasting or potentially permanent effects after a single administration. Significant long-term success has been observed in certain FDA-approved therapies for inherited disorders. However, outcomes may vary depending on the disease, the target cells, and the technology used. Long-term patient monitoring remains critically important in evaluating durability and safety.